95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
61.12%
Revenue growth 1.25-1.5x FNV's 45.82%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
80.95%
Gross profit growth above 1.5x FNV's 45.99%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
49.00%
EBIT growth 50-75% of FNV's 76.31%. Martin Whitman would suspect suboptimal resource allocation.
49.00%
Operating income growth 1.25-1.5x FNV's 32.94%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
77.62%
Net income growth above 1.5x FNV's 16.67%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
157.14%
EPS growth 1.25-1.5x FNV's 113.07%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
157.14%
Diluted EPS growth 1.25-1.5x FNV's 113.07%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
2.51%
Slight or no buybacks while FNV is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
2.79%
Diluted share count expanding well above FNV's 0.60%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
76.90%
OCF growth above 1.5x FNV's 34.15%. David Dodd would confirm a clear edge in underlying cash generation.
56.72%
FCF growth under 50% of FNV's 185.39%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
111913529.36%
10Y revenue/share CAGR above 1.5x FNV's 57.51%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
347.36%
5Y revenue/share CAGR above 1.5x FNV's 57.51%. David Dodd would look for consistent product or market expansions fueling outperformance.
88.39%
3Y revenue/share CAGR above 1.5x FNV's 57.51%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
56378.70%
10Y OCF/share CAGR above 1.5x FNV's 41.24%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
751.37%
5Y OCF/share CAGR above 1.5x FNV's 41.24%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
129.26%
3Y OCF/share CAGR above 1.5x FNV's 41.24%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1226663.69%
Net income/share CAGR above 1.5x FNV's 19.70% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
816.94%
5Y net income/share CAGR above 1.5x FNV's 19.70%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
212.66%
3Y net income/share CAGR above 1.5x FNV's 19.70%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
347.46%
5Y equity/share CAGR above 1.5x FNV's 28.81%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
82.95%
3Y equity/share CAGR above 1.5x FNV's 28.81%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.10%
Firm’s AR is declining while FNV shows 65.42%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
11.48%
Asset growth above 1.5x FNV's 3.49%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
11.57%
BV/share growth above 1.5x FNV's 3.24%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.25%
We’re deleveraging while FNV stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
29.55%
SG&A growth well above FNV's 22.91%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.